Congestive heart failure overview

end organ perfusion or symptoms • Bradycardia or heart block (first degree heart block with a PR interval > 0.24, second degree heart block, third degree heart block • Peripheral arterial disease with limb ischemia at rest • Moderate or greater peripheral edema • Recent intravenous inotropic therapy Given the potential for hemodynamic decompensation, the initiation of beta-blockers is best undertaken by an individual or center specializing in heart failure management. The patient should be aware of potential side effects, and should be aware that it may take one to three months for the beta-blockers to improve heart failure symptoms. Therapy is initiated with very low doses, and the dose of the beta-blocker should be doubled every two weeks until the target dose is achieved or symptoms prevent further dose escalation. • Carvedilol: Initial dose 3.125 mg twice daily, target dose 25 to 50 mg twice daily • Metoprolol succinate: Initial dose 12.5 mg daily, target dose 200 mg daily • Bisoprolol: Initial dose 1.25 mg daily, target dose 5 to 10 mg daily Weight gain or peripheral edema that is not responsive to diuresis may require a reduction in the dose of beta-blockers. Aldosterone Antagonism: Fourth Step in the
